Morphic Holding Inc Net Income per Employee (MORF), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Morphic Holding inc   (NASDAQ: MORF)
 

Morphic Holding Inc Net Income per Employee

MORF's Quarterly Results, Trends, Rankings, Statistics
Morphic Holding Inc recorded a cumulative net loss of $-180 million during 12 month ending in the second quarter 2024.
The Healthcare sector has seen employees of 427 other companies achieving higher income per employee. While Morphic Holding Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 4034.


What is Income per Employee Ratio?






MORF Net Income per Employee (Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -5,800,839 -5,201,742 -4,906,290 -4,378,613 -4,178,903
MORF's Total Ranking # 4034 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


MORF Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 428
Healthcare Sector # 886
Overall Market # 4034

Net Income per Employee Statistics
High Average Low
$ -686,581 $ -3,255,137 $ -5,800,839
(Mar 31 2021)   (Jun 30 2024)







Companies with similar Income per Employee for 12 month ending Jun 30 2024, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2024Number of Employees Jun 30 2024


Date modified: 2026-09-08T19:02:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.